Semba S E, Mealey B L, Hallmon W W
Department of Periodontics, Wilford Hall Medical Center, Lackland Air Force Base, Texas, USA.
Compendium. 1994 Nov;15(11):1378, 1380-7; quiz 1388.
The increase in the incidence of head and neck cancer has been accompanied by a more widespread use of chemotherapy. As a result, the dental community has frequent contact with patients who are undergoing or have undergone chemotherapy. In many of these patients, immunosuppression leads to an increased risk of infection, and the chemotherapeutic agents themselves can cause a variety of oral complications. The dentist must be familiar with available treatments for managing these conditions and for preventing further deterioration of oral and systemic health.
头颈癌发病率的上升伴随着化疗使用的更加广泛。因此，牙科领域经常接触正在接受或已经接受化疗的患者。在许多这类患者中，免疫抑制导致感染风险增加，而且化疗药物本身会引发各种口腔并发症。牙医必须熟悉用于处理这些情况以及预防口腔和全身健康进一步恶化的现有治疗方法。
